Eumentis is a biopharmaceutical company developing treatments for neuropsychiatric conditions.
Eumentis Therapeutics has raised $3.0M in total funding. The most recent round was Grant. The last funding was announced in February 2023.
Eumentis Therapeutics's investors include U.S. Department of War, Social Starts, TCA Venture Group, Joyance Partners, Life Science Angels.
Eumentis Therapeutics is headquartered in Boston, United States.
Eumentis is a biopharmaceutical company developing treatments for neuropsychiatric conditions.
Eumentis Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eumentis Therapeutics — Funding & Investors." VCBacked, February 8, 2023, https://www.vcbacked.co/company/eumentis-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). Eumentis Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/eumentis-therapeutics
{{cite web |title=Eumentis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/eumentis-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated